Curative Biosciences (Curative Biosciences) EV-to-EBITDA : -0.09 (As of May. 27, 2024)

Curative Biosciences EV-to-EBITDA Chart

Curative Biosciences Annual Data
	Trend	Jun08	Jun09	Jun10	Jun11	Jun12	Jun13	Jun14	Jun15	Jun16	Jun17
EV-to-EBITDA		Get a 7-Day Free Trial					-1.52	-32.95	-5.96	-3.98	-35.82

Curative Biosciences Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18
EV-to-EBITDA	Get a 7-Day Free Trial															-6.69	-35.82	-130.92	-10.32	-9.00

Competitive Comparison of Curative Biosciences's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Curative Biosciences's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curative Biosciences's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curative Biosciences's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Curative Biosciences's EV-to-EBITDA falls into.

Curative Biosciences EV-to-EBITDA Calculation

Curative Biosciences's EV-to-EBITDA for today is calculated as:

Curative Biosciences's current Enterprise Value is $0.05 Mil.
Curative Biosciences's EBITDA for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curative Biosciences  (OTCPK:CBDX) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Curative Biosciences's PE Ratio for today is calculated as:

Curative Biosciences's share price for today is $0.0015.
Curative Biosciences's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2018 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.034.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Curative Biosciences EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Curative Biosciences's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Curative Biosciences (Curative Biosciences) Business Description